Verona Pharma plc

VRNAStocksPharmaceuticals MajorUnited KingdomNasdaqUSD

Price

$107.01

Today

+0.0%

YTD

+0.2%

About

Verona Pharma Plc - ADR is a global clinical-stage biopharmaceutical company. The company is focused on developing and commercialising treatments for respiratory diseases. Operating as part of the biotech industry, Verona Pharma Plc’s primary service is the development of drugs to counter respiratory diseases, specifically chronic obstructive pulmonary disease (COPD), cystic fibrosis and asthma. Its product candidate ensifentrine is being developed as an inhaled treatment for respiratory disease that combines anti-inflammatory and bronchodilator activity into one compound. Stay up to date on the share price of VRNA by adding it to your eToro watchlist.

Price chart

Closing price history for VRNA (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-103.78

P/S (TTM)43.60

P/B (TTM)33.04

Market cap$9.19B

Cap tierMid-cap

Industry avg P/E-43.36

Profitability

Gross margin94.65%

EBIT margin-25.19%

Net margin11.56%

ROE-36.38%

ROA-16.13%

Earnings & Revenue

Revenue (TTM)$222.90M

Revenue growth (1Y)+1131.3%

EPS (TTM)-$1.03

Free cash flow$-73.44M

Total debt$244.37M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.01

Employees209

Next earnings3 Nov '25

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.